Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_assertion type Assertion NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_head.
- NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_assertion description "[The high potency, significant gene induction, excellent PK profiles, and good in vivo efficacies in three animal models may render compound 24 as a valuable pharmacological tool in elucidating the complex roles of PPARalpha/delta dual agonists and as a potential treatment of the metabolic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_provenance.
- NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_assertion evidence source_evidence_literature NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_provenance.
- NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_assertion SIO_000772 17608467 NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_provenance.
- NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_assertion wasDerivedFrom befree-2016 NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_provenance.
- NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_assertion wasGeneratedBy ECO_0000203 NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_provenance.